Deadline: March 3, 2025
Applications are open for the Lung Cancer Research Foundation (LCRF) Research Grant on Prevention and Early Detection in Lung Cancer 2025. Given the significance and need for early detection of lung cancer and advancements in molecular screening, LCRF continues to offer a funding mechanism to support research projects that facilitate or advance the understanding and characterization of approaches for early detection of lung cancer. Work supported through this mechanism addresses important questions in non-small cell and small cell lung cancer.
This funding mechanism is focused on identifying, characterizing, and developing approaches and techniques that will allow early detection and/or risk reduction of lung cancer and gaining insight into pre-neoplastic processes in the lungs. The ultimate goal is to detect lung cancer at the earliest stages and subsequently increase survival and survivorship. The program is designed to support early-stage researchers and faculty within the first 10 years of their faculty appointment. While this list is not exclusive, general areas of interest include:
- Improvements in risk stratification of patients and uptake for screening
- Identification and characterization of new biomarkers for NSCLC and SCLC
- Development of predictive, diagnostic, or prognostic biomarkers
- Liquid biopsy assays and related techniques
- Genomic and histological approaches to improve early detection in tissue samples
- Novel imaging and computational modalities to identify and risk stratify pre-neoplastic lesions
- Implementation science with systematic uptake of evidence-based research findings into routine practices to improve quality and effectiveness of health services for early detection
- Studies of pre-neoplasia and progression to lung neoplasia to inform prevention strategies
- Development of pathways to increase uptake and utilization of lung cancer screening
- Epidemiology studies to identify risk factors and implementation of prevention measures
- Development of any new technologies that will aid in identifying early-stage lung cancers
Grant
- The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).
Eligibility
- Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.
- Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.
- Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years.
- Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics.
Application
Applications will be submitted through a two-step process consisting of a Letter of Intent (LOI) and full proposal. Applicants whose LOI submission is reviewed favorably will be invited to complete a full proposal. Applicants may only apply for one LCRF grant per grant cycle.
For more information, visit LCRF Research Grant.
